Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Impinj
PI
$4.62B
| $2.18M | ﹤0.01% |
24,600
+15,961
| +185% | +$1.16M |
|
2327
Seres Therapeutics
MCRB
$46.8M
| $2.18M | ﹤0.01% |
13,085
+10,688
| +446% | +$1.7M |
|
|
CSW
2328
CSW Industrials
CSW
$5.2B
| $2.18M | ﹤0.01% |
18,023
+9,905
| +122% | +$1.29M |
|
2329
MDU Resources
MDU
$4.17B
| $2.17M | ﹤0.01% |
185,139
-253,768
| -58% | -$2.86M |
|
2330
Protolabs
PRLB
$1.79B
| $2.17M | ﹤0.01% |
42,271
+13,685
| +48% | +$807K |
|
|
XENT
2331
DELISTED
Intersect ENT, Inc
XENT
| $2.16M | ﹤0.01% |
79,194
-34,320
| -30% | -$930K |
|
|
RWT
2332
Redwood Trust
RWT
$574M
| $2.16M | ﹤0.01% |
163,884
+60,251
| +58% | +$815K |
|
2333
Malibu Boats
MBUU
$541M
| $2.16M | ﹤0.01% |
31,433
+14,475
| +85% | +$1.02M |
|
2334
Oxford Industries
OXM
$566M
| $2.15M | ﹤0.01% |
21,186
-2,206
| -9% | -$215K |
|
|
CVSA
2335
Covista Inc
CVSA
$4.25B
| $2.15M | ﹤0.01% |
72,713
+28,706
| +65% | +$946K |
|
2336
iShare MSCI Eurozone ETF
EZU
$9.64B
| $2.15M | ﹤0.01% |
43,861
-153,699
| -78% | -$7.57M |
|
2337
Varex Imaging
VREX
$472M
| $2.15M | ﹤0.01% |
68,085
+35,001
| +106% | +$992K |
|
|
VGR
2338
DELISTED
Vector Group Ltd.
VGR
| $2.14M | ﹤0.01% |
186,437
-9,805
| -5% | -$105K |
|
2339
Liberty Latin America Class C
LILAK
$1.63B
| $2.14M | ﹤0.01% |
206,421
+111,182
| +117% | +$1.23M |
|
2340
Timken Company
TKR
$9.56B
| $2.14M | ﹤0.01% |
30,874
-45,963
| -60% | -$3.22M |
|
2341
Preferred Bank
PFBC
$1.24B
| $2.14M | ﹤0.01% |
29,774
+11,238
| +61% | +$777K |
|
2342
Mesa Laboratories
MLAB
$564M
| $2.13M | ﹤0.01% |
6,506
+1,185
| +22% | +$372K |
|
2343
e.l.f. Beauty
ELF
$4.89B
| $2.13M | ﹤0.01% |
64,112
+5,862
| +10% | +$182K |
|
|
IRBT
2344
CALL
DELISTED
iRobot
IRBT
| $2.13M | ﹤0.01% |
32,300
| – | – |
|
|
RODI
2345
DELISTED
iPath Return on Disability ETN
RODI
| $2.12M | ﹤0.01% |
16,500
| – | – |
|
2346
Frontline
FRO
$8.76B
| $2.12M | ﹤0.01% |
299,770
-264,944
| -47% | -$2.11M |
|
|
SAFE
2347
DELISTED
Safehold Inc.
SAFE
| $2.12M | ﹤0.01% |
26,524
+8,367
| +46% | +$617K |
|
2348
Horace Mann Educators
HMN
$2.1B
| $2.11M | ﹤0.01% |
54,474
+21,234
| +64% | +$833K |
|
|
ATSG
2349
DELISTED
Air Transport Services Group
ATSG
| $2.1M | ﹤0.01% |
71,643
+40,578
| +131% | +$1.08M |
|
2350
Genpact
G
$5.96B
| $2.1M | ﹤0.01% |
39,623
-216,194
| -85% | -$10.9M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.